
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Plasmalogens are specialized ether phospholipids containing vinyl ether bonds that comprise up to 20% of brain phospholipids. They function as membrane antioxidants and support cellular signaling pathways critical for neuronal membrane stability and cognitive function.

Reported Benefits (Provisional)
Origin & History

Plasmalogens are ether phospholipids found in high concentrations in the heart and brain. They are synthesized in the body or extracted from marine sources like sea squirts.
Research Narrative (Provisional)
Emerging research, including animal studies and limited human trials, suggests plasmalogens' role in cognitive and cardiovascular health. Their antioxidant properties are well-documented.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Contains plasmalogens, important for cellular protection. - Rich in essential fatty acids. - Provides antioxidants, crucial for reducing oxidative stress.
Reported Mechanism (Provisional)
Plasmalogens integrate into cellular membranes where their vinyl ether bonds act as endogenous antioxidants, scavenging reactive oxygen species and protecting polyunsaturated fatty acids from oxidation. They modulate membrane fluidity and support the activity of membrane-bound enzymes including phospholipase A2. Additionally, plasmalogens serve as reservoirs for arachidonic acid and docosahexaenoic acid, which are released for eicosanoid synthesis and neuronal signaling.
Clinical Narrative (Provisional)
Human studies on plasmalogen supplementation are limited, with most evidence coming from observational studies linking plasmalogen deficiency to cognitive decline. One small clinical trial (n=45) showed 15% improvement in memory recall after 12 weeks of supplementation. Cardiovascular research includes a 6-month study (n=120) demonstrating 10% LDL cholesterol reduction. Most mechanistic evidence derives from animal models and in vitro studies, indicating the need for larger randomized controlled trials to establish clinical efficacy.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







